1.240USD+0.81%Mkt Cap: 14.23M USDP/E: —Last update: 2026-05-22
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers …
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Company
Market Cap14.23M USD
Enterprise Value16.72M USD
Revenue (TTM)28.74M USD
Gross Profit13.19M USD
Net Income (TTM)-26.39M USD
Revenue/Share3.823 USD
Last Price1.240 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees95
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.11
PEG—
EV/EBITDA-0.72
EV/Revenue0.58
P/S0.49
P/B0.37
EPS (TTM)-4.46
EPS (Forward)-1.11
52W Range
1.0604% of range5.500
52W High5.500 USD
52W Low1.060 USD
Profitability
Gross Margin46.25%
Oper. Margin-118.09%
EBITDA Margin-81.31%
Profit Margin-92.59%
ROE-59.42%
ROA-35.87%
Growth
Revenue Growth3.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.34M USD
CapEx (TTM)—
FCF Margin-19.95%
FCF Yield-40.30%
Net Debt2.61M USD
Net Debt/EBITDA-0.11
Balance Sheet
Debt/Equity0.16
Current Ratio1.84
Quick Ratio0.87
Book Value/Sh3.322 USD
Cash/Share1.255 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:60
Split DateJan 27, 2025
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Target Range4.000 USD – 6.000 USD
# Analysts2
Ownership
Shares Out.11.47M
Float10.30M
Insiders7.40%
Institutions10.12%
Short Interest
Short Ratio9.4d
Short % Float10.16%
Short % Out.10.15%
Shares Short1.13M
Short (prev mo.)1.23M
Technical
SMA 501.203 (+3.1%)
SMA 2001.768 (-29.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)153.95K
Avg Vol (10d)189.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—